Media

Vicore Pharma – Interim report April-June 2024

Adcendo ApS and Multitude Therapeutics Inc. Announce Global Development and Commercialization Agreement on First-in-class ADC Drug Candidate Targeting Tissue Factor

Oncopeptides publishes Q2 report 2024

Spruce Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

Aprea Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Carisma Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Oncopeptides – Invitation to presentation of the Q2 report 2024

Carisma Therapeutics Announces Expansion of Its Scientific Advisory Board

Pulmonx Reports Second Quarter 2024 Financial Results

Ariceum Therapeutics Commences Phase 1 Clinical Trial in Patients with Recurrent Glioblastoma